Current Opinion in Pharmacology : Impact Factor & More
eISSN: 1471-4973pISSN: 1471-4892
Share this on:
Key Metrics
CiteScore 
8.8
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.07
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Opinion in Pharmacology
Current Opinion in Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Opinion in Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Opinion in Pharmacology
Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk.
- 1 Dec 2026
- Current opinion in pharmacology
Cyclosporine A revisited: Molecular mechanisms, non-immune physiological pathways, and the architecture of multi-organ toxicities.
- 1 Dec 2026
- Current opinion in pharmacology
Pharmacological control of inflammation via innate immune memory manipulation.
- 1 Dec 2026
- Current opinion in pharmacology
Polycystic ovary syndrome: An insight into pathophysiology, current management, and emerging therapeutic approaches.
- 1 Dec 2026
- Current opinion in pharmacology
Piezo1 and Piezo2 in neurological disorders: From mechanotransduction to therapeutic potential.
- 1 Dec 2026
- Current opinion in pharmacology
Editorial: The future of inflammatory bowel disease is integration.
- 1 Dec 2026
- Current opinion in pharmacology
Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk.
- 1 Dec 2026
- Current opinion in pharmacology
Cyclosporine A revisited: Molecular mechanisms, non-immune physiological pathways, and the architecture of multi-organ toxicities.
- 1 Dec 2026
- Current opinion in pharmacology
Pharmacological control of inflammation via innate immune memory manipulation.
- 1 Dec 2026
- Current opinion in pharmacology
Polycystic ovary syndrome: An insight into pathophysiology, current management, and emerging therapeutic approaches.
- 1 Dec 2026
- Current opinion in pharmacology
Piezo1 and Piezo2 in neurological disorders: From mechanotransduction to therapeutic potential.
- 1 Dec 2026
- Current opinion in pharmacology
Editorial: The future of inflammatory bowel disease is integration.
- 1 Dec 2026
- Current opinion in pharmacology
FAQs on Current Opinion in Pharmacology
How long has Current Opinion in Pharmacology been actively publishing? 
What is the publishing frequency of Current Opinion in Pharmacology?
How many articles did Current Opinion in Pharmacology publish last year?
What is the eISSN & pISSN for Current Opinion in Pharmacology?
What is Citescore for Current Opinion in Pharmacology?
What is SNIP score for Current Opinion in Pharmacology?
What is the SJR for Current Opinion in Pharmacology?
Who is the publisher of Current Opinion in Pharmacology?
